Overview

Nasal Oxcytocin During IUI

Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Placebo-controlled study. Application of nasal oxytocin (8 IU) during intrauterine insemination in 86 patients.
Phase:
N/A
Details
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborators:
Essex Pharma GmbH
Organon GmbH (former name)
Treatments:
Oxytocin